Alpha Teknova, Inc. (TKNO)
NASDAQ: TKNO · Real-Time Price · USD
7.64
-0.10 (-1.27%)
Nov 21, 2024, 1:08 PM EST - Market open
Alpha Teknova Revenue
Alpha Teknova had revenue of $9.58M in the quarter ending September 30, 2024, with 17.22% growth. This brings the company's revenue in the last twelve months to $36.35M, down -0.98% year-over-year. In the year 2023, Alpha Teknova had annual revenue of $36.68M, down -11.43%.
Revenue (ttm)
$36.35M
Revenue Growth
-0.98%
P/S Ratio
9.29
Revenue / Employee
$172,261
Employees
211
Market Cap
407.37M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Cross Country Healthcare | 1.45B |
Viemed Healthcare | 214.30M |
AVITA Medical | 60.04M |
Semler Scientific | 58.94M |
AC Immune | 48.51M |
CVRx, Inc. | 47.26M |
Aclaris Therapeutics | 27.08M |
Silence Therapeutics | 21.77M |
TKNO News
- 12 days ago - Alpha Teknova, Inc. (TKNO) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 13 days ago - Teknova Reports Third Quarter 2024 Financial Results - GlobeNewsWire
- 27 days ago - Teknova to Report Third Quarter 2024 Financial Results on November 7, 2024 - GlobeNewsWire
- 3 months ago - Alpha Teknova, Inc. (TKNO) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Teknova Reports Second Quarter 2024 Financial Results - GlobeNewsWire
- 4 months ago - Teknova to Report Second Quarter 2024 Financial Results on August 13, 2024 - GlobeNewsWire
- 4 months ago - Teknova Announces Closing of $15.4 Million Private Placement - GlobeNewsWire
- 4 months ago - Teknova Announces $15.4 Million Private Placement - GlobeNewsWire